Vericel (VCEL) EPS (Weighted Average and Diluted): 2010-2025
Historic EPS (Weighted Average and Diluted) for Vericel (VCEL) over the last 9 years, with Sep 2025 value amounting to $0.10.
- Vericel's EPS (Weighted Average and Diluted) rose 600.00% to $0.10 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.25, marking a year-over-year increase of 257.14%. This contributed to the annual value of $0.20 for FY2024, which is 385.71% up from last year.
- According to the latest figures from Q3 2025, Vericel's EPS (Weighted Average and Diluted) is $0.10, which was up 1,100.00% from -$0.01 recorded in Q2 2025.
- In the past 5 years, Vericel's EPS (Weighted Average and Diluted) registered a high of $0.39 during Q4 2024, and its lowest value of -$0.23 during Q1 2025.
- Its 3-year average for EPS (Weighted Average and Diluted) is -$0.00, with a median of -$0.08 in 2024.
- In the last 5 years, Vericel's EPS (Weighted Average and Diluted) crashed by 237.50% in 2021 and then spiked by 600.00% in 2025.
- Quarterly analysis of 5 years shows Vericel's EPS (Weighted Average and Diluted) stood at $0.10 in 2021, then spiked by 30.00% to $0.13 in 2022, then surged by 107.69% to $0.27 in 2023, then surged by 44.44% to $0.39 in 2024, then skyrocketed by 600.00% to $0.10 in 2025.
- Its last three reported values are $0.10 in Q3 2025, -$0.01 for Q2 2025, and -$0.23 during Q1 2025.